AKR1B10 and metastatic malignant neoplasm in the lymph nodes: In contrast, GC patients with AKR1B10 overexpression had advanced lymph node metastasis, fewer tumor regression, and worse overall survival (OS) compared to those with negative expression of AKR1B10 [25].